Early electroretinographic features of streptozotocin-induced diabetic retinopathy

Clinical and Experimental Ophthalmology

Volumn 35, Issue 9, 2007, Pages 847-854

  Shinoda, Kei ^a,b   Rejdak, Robert ^a,c,f   Schuettauf, Frank ^a   Blatsios, Georgios ^a   Völker, Michael ^a   Tanimoto, Naoyuki ^d   Olcay, Tatar ^a   Gekeler, Florian ^a   Lehaci, Cristina ^a   Naskar, Rita ^e   Zagorski, Zbigniew ^c   Zrenner, Eberhart ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b OITA UNIVERSITY   (Japan)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Diabetic retinopathy; Electroretinogram; Rat; Retina; Streptozotocin

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; STREPTOZOCIN;

A WAVE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ACTIVITY; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MUELLER CELL; NONHUMAN; OSCILLATORY POTENTIAL; PHOTORECEPTOR; RAT; RETINA; SENSITIVITY ANALYSIS; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, INBRED BN; RETINA; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 37549037046     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2007.01607.x     Document Type: Article

References (45)

1. Prevent Blindness America. Vision Problems in the US: A Report on Blindness and Vision Impairment in Adults Age 40 and Older. Schaumburg, IL: Prevent Blindness America, 1994.
2. Yonemura D, Aoki T, Tsuzuki K. Electroretinogram in diabetic retinopathy. Arch Ophthalmol 1962; 68: 19-24.
3. Simonsen SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol 1980; 58: 865-78.
4. Bresnick GH, Korth K, Groo A, Palta M. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol 1984; 102: 1307-11.
5. Bresnick GH, Palta M. Predicting progression to severe proliferative diabetic retinopathy. Arch Ophthalmol 1987; 105: 810-4.
6. Holopigian K, Greenstein VC, Seiple W, Hood DC, Carr RE. Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 1997; 38: 2355-65.
7. Aylward GW. The scotopic threshold response in diabetic retinopathy. Eye 1989; 3: 626-37.
8. Juen S, Kieselbach GF. Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol 1990; 108: 372-5.
9. Holopigian K, Seiple W, Lorenzo M, Carr R. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest Ophthalmol Vis Sci 1992; 33: 2773-80.
10. Satoh S, Iijima H, Imai M, Abe K, Shibuya T. Photopic electroretinogram implicit time in diabetic retinopathy. Jpn J Ophthalmol 1994; 38: 178-84.
11. Lieth E, Barber AJ, Xu B et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 1998; 47: 815-20. Erratum in: Diabetes 1998; 47: 1170.
12. Rungger-Brandle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 2000; 41: 1971-80.
13. Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 2000; 17: 463-71.
14. Agardh E, Bruun A, Agardh CD. Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes. Curr Eye Res 2001; 23: 276-84.
15. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 2000; 41: 3561-8.
16. Barber AJ, Antonetti DA. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Invest Ophthalmol Vis Sci 2003; 44: 5410-6.
17. Pautler EL, Ennis SR. The effect of induced diabetes on the electroretinogram components of the pigmented rat. Invest Ophthalmol Vis Sci 1980; 19: 702-5.
18. Sakai H, Tani Y, Shirasawa E, Shirao Y, Kawasaki K. Development of electroretinographic alterations in streptozotocin-induced diabetes in rats. Ophthalmic Res 1995; 27: 57-63.
19. Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in experimental diabetes: Electroretinographical and morphological observations. Exp Eye Res 2002; 74: 615-25.
20. Dalke C, Löster J, Fuchs H et al. Electroretinography as a screening method for mutations causing retinal dysfunction in mice. Invest Ophthalmol Vis Sci 2004; 45: 601-9.
21. Hood DC, Shady S, Birch DG. Understanding changes in the b-wave of the ERG caused by heterogeneous receptor damage. Invest Ophthalmol Vis Sci 1994; 35: 2477-88.
22. Naka KI, Rushton WA. S-potentials from luminosity units in the retina of fish (Cyprinidae). J Physiol 1966; 185: 587-99.
23. Roecker EB, Pulos E, Bresnick GH, Severns M. Characterization of the electroretinographic scotopic B-wave amplitude in diabetic and normal subjects. Invest Ophthalmol Vis Sci 1992; 33: 1575-83.
24. Velten IM, Horn FK, Korth M, Velten K. The b-wave of the dark adapted flash electroretinogram in patients with advanced asymmetrical glaucoma and normal subjects. Br J Ophthalmol 2001; 85: 403-9.
25. Hood DC, Birch DG. Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci 1994; 35: 2948-61.
26. Hood DC, Birch DG. Assessing abnormal rod photoreceptor activity with the a-wave of the electroretinogram: Applications and methods. Doc Ophthalmol 1996; 92: 253-67.
27. Bresnick GH. Diabetic retinopathy viewed as a neurosensory disorder. Arch Ophthalmol 1986; 104: 989-90.
28. Dosso AA, Bonvin ER, Morel Y, Golay A, Assal JP, Leuenberger PM. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol 1996; 234: 300-5.
29. Di Leo MA, Caputo S, Falsini B et al. Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care 1992; 15: 620-5.
30. Harris A, Arend O, Danis RP, Evans D, Wolf S, Martin BJ. Hyperoxia improves contrast sensitivity in early diabetic retinopathy. Br J Ophthalmol 1996; 80: 209-13.
31. Hardy KJ, Lipton J, Scase MO, Foster DH, Scarpello JH. Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. Br J Ophthalmol 1992; 76: 461-4.
32. Hardy KJ, Scarpello JH, Foster DH, Moreland JD. Effect of diabetes associated increases in lens optical density on colour discrimination in insulin dependent diabetes. Br J Ophthalmol 1994; 78: 754-6.
33. Bresnick GH, Palta M. Oscillatory potential amplitudes. Relation to severity of diabetic retinopathy. Arch Ophthalmol 1987; 105: 929-33.
34. Arden GB, Hamilton AM, Wilson-Holt J, Ryan S, Yudkin JS, Kurtz A. Pattern electroretinograms become abnormal when background diabetic retinopathy deteriorates to a preproliferative stage: Possible use as a screening test. Br J Ophthalmol 1986; 70: 330-5.
35. Karadeniz S, Kir N, Yilmaz MT etal. Alteration of visual function in impaired glucose tolerance. Eur J Ophthalmol 1996; 6: 59-62.
36. Ogden TE. The oscillatory waves of the primate electroretinogram. Vision Res 1973; 13: 1059-74.
37. Speros P, Price J. Oscillatory potentials. History, techniques and potential use in the evaluation of disturbances of retinal circulation. Surv Ophthalmol 1981; 25: 237-52.
38. Wachtmeister L. Basic research and clinical aspects of the oscillatory potentials of the electroretinogram. Doc Ophthalmol 1987; 66: 187-94.
39. Park SH, Park JW, Park SJ et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 2003; 46: 1260-8.
40. Do carmo A, Ramos P, Reis A, Proenca R, Cunha-vaz JG. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes. Exp Eye Res 1998; 67: 569-75.
41. King-Smith PE, Loffing DH, Jones R. Rod and cone ERGs and their oscillatory potentials. Invest Ophthalmol Vis Sci 1986; 27: 270-3.
42. Janaky M, Goupland SG, Benedek G. Human oscillatory potentials: components of rod origin. Ophthalmologica 1996; 210: 315-8.
43. Rousseau S, Lachapelle P. The electroretinogram recorded at the onset of dark-adaptation: Understanding the origin of the scotopic oscillatory potentials. Doc Ophthalmol 1999; 99: 135-50.
44. Goto Y, Peachey NS, Ripps H, Naash MI. Functional abnormalities in transgenic mice expressing a mutant rhodopsin gene. Invest Ophthalmol Vis Sci 1995; 36: 62-71.
45. Sieving PA, Murayama K, Naarendorp F. Push-pull model of the primate photopic electroretinogram: A role for hyperpolarizing neurons in shaping the b-wave. Vis Neurosci 1994; 11: 519-32.